The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Multifunctional Mesoporous Silica Nanoparticles for Cancer‐Targeted and Controlled Drug Delivery
Abstract
Multifunctional mesoporous silica nanoparticles are developed in order to deliver anticancer drugs to specific cancer cells in a targeted and controlled manner. The nanoparticle surface is functionalized with amino‐β‐cyclodextrin rings bridged by cleavable disulfide bonds, blocking drugs inside the mesopores of the nanoparticles. Poly(ethylene glycol) polymers, functionalized with an adamantane unit at one end and a folate unit at the other end, are immobilized onto the nanoparticle surface through strong β‐cyclodextrin/adamantane complexation. The non‐cytotoxic nanoparticles containing the folate targeting units are efficiently trapped by folate‐receptor‐rich HeLa cancer cells through receptormmediated endocytosis, while folate‐receptor‐poor human embryonic kidney 293 normal cells show much lower endocytosis towards nanoparticles under the same conditions. The nanoparticles endocytosed by the cancer cells can release loaded doxorubicin into the cells triggered by acidic endosomal pH. After the nanoparticles escape from the endosome and enter into the cytoplasm of cancer cells, the high concentration of glutathione in the cytoplasm can lead to the removal of the β‐cyclodextrin capping rings by cleaving the pre‐installed disulfide bonds, further promoting the release of doxorubicin from the drug carriers. The high drug‐delivery efficacy of the multifunctional nanoparticles is attributed to the co‐operative effects of folate‐mediated targeting and stimuli‐triggered drug release. The present delivery system capable of delivering drugs in a targeted and controlled manner provides a novel platform for the next generation of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Mesoporous silica nanoparticles deliver DNA and chemicals into plants
Torney, F., Trewyn, B. G., Lin, V. S.-Y., & Wang, K. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.108 · Cited by 1,481
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200250653 · Cited by 1,329
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
Carlsson, J., Drevin, H., & Axén, R. (1978) · Biochemical Journal · doi:10.1042/bj1730723 · Cited by 1,215
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs
Lu, J., Liong, M., Zink, J. I., & Tamanoi, F. (2007) · Small · doi:10.1002/smll.200700005 · Cited by 1,012
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Slowing, I., Trewyn, B. G., & Lin, V. S.-Y. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0645943 · Cited by 846
Glutathione-Mediated Delivery and Release Using Monolayer Protected Nanoparticle Carriers
Hong, R., Han, G., Fernández, J. M., Kim, B.-J., Forbes, N. S., & Rotello, V. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056726i · Cited by 817
Motornov, M., Roiter, Y., Tokarev, I., & Minko, S. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.10.004 · Cited by 773
Dilute Solution Routes to Various Controllable Morphologies of MCM-41 Silica with a Basic Medium
Cai, Q., Luo, Z.-S., Pang, W.-Q., Fan, Y.-W., Chen, X.-H., & Cui, F.-Z. (2001) · Chemistry of Materials · doi:10.1021/cm990661z · Cited by 679
He, Q., Zhang, Z., Gao, F., Li, Y., & Shi, J. (2011) · Small · doi:10.1002/smll.201001459 · Cited by 661
Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine
Ambrogio, M. W., Thomas, C. R., Zhao, Y.-L., Zink, J. I., & Stoddart, J. F. (2011) · Accounts of Chemical Research · doi:10.1021/ar200018x · Cited by 604
Self-citationMeng, H., Xue, M., Xia, T., Zhao, Y.-L., Tamanoi, F., Stoddart, J. F., Zink, J. I., & Nel, A. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104501a · Cited by 595
Self-citationRosenholm, J. M., Sahlgren, C., & Lindén, M. (2010) · Nanoscale · doi:10.1039/c0nr00156b · Cited by 572
Meng, H., Xue, M., Xia, T., Ji, Z., Tarn, D. Y., Zink, J. I., & Nel, A. E. (2011) · ACS Nano · doi:10.1021/nn200809t · Cited by 509
Nguyen, T. D., Tseng, H.-R., Celestre, P. C., Flood, A. H., Liu, Y., Stoddart, J. F., & Zink, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504109102 · Cited by 463
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 402
Design and Optimization of Molecular Nanovalves Based on Redox-Switchable Bistable Rotaxanes
Nguyen, T. D., Liu, Y., Saha, S., Leung, K. C.-F., Stoddart, J. F., & Zink, J. I. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065485r · Cited by 397
Park, C., Kim, H., Kim, S., & Kim, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9061085 · Cited by 396
Tunable Redox-Responsive Hybrid Nanogated Ensembles
Liu, R., Zhao, X., Wu, T., & Feng, P. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8060886 · Cited by 391
Kim, H., Kim, S., Park, C., Lee, H., Park, H. J., & Kim, C. (2010) · Advanced Materials · doi:10.1002/adma.201001417 · Cited by 356
Prabaharan, M., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.011 · Cited by 317
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
Zhao, Y.-L., Li, Z., Kabehie, S., Botros, Y. Y., Stoddart, J. F., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105371u · Cited by 304
Self-citationSchlossbauer, A., Kecht, J., & Bein, T. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805818 · Cited by 299
Saha, S., Leung, K. C. ‐., Nguyen, T. D., Stoddart, J. F., & Zink, J. I. (2007) · Advanced Functional Materials · doi:10.1002/adfm.200600989 · Cited by 296
Peng, C., Zhang, H., Yu, J., Meng, Q., Fu, L., Li, H., Sun, L., & Guo, X. (2005) · The Journal of Physical Chemistry B · doi:10.1021/jp051984n · Cited by 276
Park, C., Lee, K., & Kim, C. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200803880 · Cited by 255
Enzyme‐Responsive Controlled Release Using Mesoporous Silica Supports Capped with Lactose
Bernardos, A., Aznar, E., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., Soto, J., Barat, J. M., & Amorós, P. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900880 · Cited by 250
Rim, H. P., Min, K. H., Lee, H. J., Jeong, S. Y., & Lee, S. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101536 · Cited by 247
Designer Biomaterials for Nanomedicine
Doshi, N., & Mitragotri, S. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901538 · Cited by 238
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie · doi:10.1002/ange.200250653 · Cited by 221
DNA Block Copolymer Micelles – A Combinatorial Tool for Cancer Nanotechnology
Alemdaroglu, F. E., Alemdaroglu, N. C., Langguth, P., & Herrmann, A. (2008) · Advanced Materials · doi:10.1002/adma.200700866 · Cited by 191
Lim, Y.-B., Kim, S.-M., Lee, Y., Lee, W.-K., Yang, T.-G., Lee, M.-J., Suh, H., & Park, J.-S. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005715g · Cited by 138
Programmed drug delivery: nanosystems for tumor targeting
Wagner, E. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.587 · Cited by 137
Yang, Y., Aw, J., Chen, K., Liu, F., Padmanabhan, P., Hou, Y., Cheng, Z., & Xing, B. (2011) · Chemistry - An Asian Journal · doi:10.1002/asia.201000905 · Cited by 93
Self-citationEnzyme‐Responsive Controlled Release Using Mesoporous Silica Supports Capped with Lactose
Bernardos, A., Aznar, E., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., Soto, J., Baviera, J. M. B., & Amorós, P. (2009) · Angewandte Chemie · doi:10.1002/ange.200900880 · Cited by 86
Schloßbauer, A., Kecht, J., & Bein, T. (2009) · Angewandte Chemie · doi:10.1002/ange.200805818 · Cited by 84
Recent Advances from the National Cancer Institute Alliance for Nanotechnology in Cancer
Farrell, D. F., Alper, J., Ptak, K., Panaro, N. J., Grodzinski, P. A., & Barker, A. D. (2010) · ACS Nano · doi:10.1021/nn100073g · Cited by 75
Nanomedizin – Herausforderung und Perspektiven
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Mauro Ferrari, B., & Fuchs, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802585 · Cited by 74
Park, C., Lee, K., & Kim, C. (2009) · Angewandte Chemie · doi:10.1002/ange.200803880 · Cited by 56
Cited by
Biomedical Applications of Supramolecular Systems Based on Host–Guest Interactions
Ma, X., & Zhao, Y. (2015) · Chemical Reviews · doi:10.1021/cr500392w · Cited by 1,225
Self-citationMultifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
Argyo, C., Weiss, V., Bräuchle, C., & Bein, T. (2014) · Chemistry of Materials · doi:10.1021/cm402592t · Cited by 903
Mesoporous silica nanoparticles in target drug delivery system: A review
Bharti, C., Gulati, N., Nagaich, U., & Pal, A. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.160844 · Cited by 817
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Gated Materials for On-Command Release of Guest Molecules
Aznar, E., Oroval, M., Pascual, L., Murguía, J. R., Martínez-Máñez, R., & Sancenón, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00456 · Cited by 488
Metadata
- Authors
- Zhang, Q., Liu, F., Nguyen, K. T., Ma, X., Wang, X., Xing, B., & Zhao, Y.
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2012-07-30
- Volume
- 22
- Issue
- 24
- Pages
- 5144-5156
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W2112246960
- Cited by
- 324
- References
- 53
- FWCI
- 14.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.